Revolutionizing IBD Care

We look forward to seeing you in person at the 2025 Crohn’s & Colitis Congress®, taking place February 6–8, 2025, in San Francisco. 

Join your colleagues from around the world and across the entire spectrum of clinical care and science at the premier conference on inflammatory bowel disease (IBD). Don’t miss your opportunity to gain a multidisciplinary perspective on treating IBD. Discover different perspectives, leave with practical information you can immediately implement, and hear about potential treatments on the horizon.

The Crohn’s & Colitis Congress is a partnership of the Crohn’s & Colitis Foundation and the American Gastroenterological Association. Many thanks to our attendees, chairs, faculty, exhibitors, supporting organizations and partners for making the 2024 Congress such a success.  

See how to obtain CME and MOC credit from the 2024 Congress.

Please check back for updates. 

Transforming IBD Care

We are thrilled to announce the Crohn’s & Colitis Congress®, a partnership of the Crohn’s & Colitis Foundation and the American Gastroenterological Association, will take place on January 25-27, 2024, at the Bellagio in Las Vegas.

Join your colleagues from around the world and across the entire spectrum of clinical care and science at the premier conference on inflammatory bowel disease (IBD) as we continue our mission of transforming IBD care. 

Don’t miss all the excitement! Gain a multidisciplinary perspective on treating IBD. Discover different perspectives, leave with practical information you can immediately implement, and hear about potential treatments on the horizon.

We look forward to seeing you in person. Please check back for updates. 

2022 Crohn's & Colitis Congress Goes Virtual

The Crohn’s & Colitis Foundation and AGA have cancelled in-person programming due to the challenges the coronavirus omicron variant outbreak places on the medical community. In order to have the safest and most educational meeting, all Crohn’s & Colitis Congress programming will be held virtually on January 20-22. 

Speakers, moderators and poster presenters will receive more details by email later this week about your virtual participation.

Exhibitors will be contacted directly by a member of Congress management for further details. 

Attendees: All registrations will be converted to virtual and housing reservations will be cancelled.

We look forward to a dynamic and educational virtual and on-demand experience.  Thank you for your patience with this transition. We share our best wishes for your health and safety.

 

WE HOPE TO SEE YOU VIRTUALLY ON JANUARY 20–22, 2022. 

Important Dates

Abstract Notifications: Monday, December 5, 2022

Advanced Registration Deadline: Wednesday, December 14, 2022

Important Dates

Registration

Regular Registration Deadline: Wednesday, January 17, 2024

Why You Should Attend the Crohn’s & Colitis Congress

Drs. Peter Higgins and Laura Raffals reveal why they are excited to bring you the 2024 Congress.

You can still register to join the live meeting. If you miss anything, the on-demand programming will be released on February 1, 2021, and be available for 90 days.

2024 Crohn's & Colitis Congress Chairs

Peter D. R. Higgins, MD, PhD, AGAF

Co-Chair, Organizing Committee
University of Michigan

Laura E. H. Raffals, MD, MS

Co-Chair, Organizing Committee
Mayo Clinic

Supporting Organizations

The 2024 Crohn’s & Colitis Congress was supported by an educational grant from: 

Ferring Pharmaceuticals, Inc.

Lilly

Pfizer

Salix Pharmaceuticals, Inc.

Takeda Pharmaceuticals U.S.A., Inc.

Bristol Myers Squibb

AbbVie Inc.

Salix Pharmaceuticals, a division of Bausch Health US, LLC

Pfizer Inc.

Takeda Pharmaceuticals U.S.A., Inc.

Recognition

The 2024 Crohn’s & Colitis Congress partnered with:

Media Partners

The 2024 Crohn’s & Colitis Congress partnered with:

This website uses cookies to provide you with the best experience on our website. If you wish to disable cookies, please do so in your browser settings. Your continued use of our site without disabling your cookies is subject to the cookie policy. Learn More